| URN | urn:agi-cas:74-79-3 |
|---|---|
| Total Entities | 11 |
| Connectivity | 3429 |
| Name | arginine |
| ChildConcepts | agmatine |
|---|---|
| D-arginine | |
| E-64 | |
| L-Arginine butanoate | |
| polyarginine | |
| Glutargin | |
| BAEE | |
| arginine aspartate | |
| adiuvant | |
| CI 949 | |
| Sulfile |
| Pathway | Translation |
|---|---|
| NO Synthesis in Early Vasospasm | |
| CFTR-Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations) | |
| Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension | |
| Hemolysis-Associated Arterial Pulmonary Hypertension | |
| NO and ADMA Signaling in Raynaud Disease | |
| Regulation of Vascular Reactivity in Raynaud Disease | |
| Role of Scavenger Receptor OLR1 in Inflammation-Related Endothelial Dysfunction in Atherosclerosis | |
| Serine and Glycine metabolism | |
| Ser/Gly/Thr/Cys metabolism | |
| Urea cycle and arginine metabolism | |
| Aspartate metabolism | |
| Malonate, propanoate and beta-alanine metabolism | |
| ROS and RNS in the Regulation of Vasoconstriction and Vasodilation | |
| ROS in Neutrophil-Mediated Cell Damage | |
| Protein Oxidation and Nitration Products as Disease Biomarkers | |
| histone modification pathway | |
| histone modification pathway | |
| histone modification pathway |
| Group | Biofluids assayable substances |
|---|
| Source | ChemIDplus |
|---|
| Alias | 7200-25-1 |
|---|---|
| 7004-12-8 | |
| 4455-52-1 | |
| 17806-42-7 | |
| 15595-35-4 | |
| 142-49-4 | |
| 1119-34-2 | |
| EINECS 200-811-1 | |
| Arginine Hydrochloride | |
| Arginine | |
| Arginine monohydrochloride | |
| Argininum | |
| Argivene | |
| BRN 1725413 | |
| CCRIS 3609 | |
| 74-79-3 | |
| levo arginine | |
| Arginine monochloride | |
| arginyl residue | |
| (1-carboxy-4-guanidino-butyl)ammonium HCl | |
| levo arginine HCl | |
| (+)-L-Arginine HCl | |
| L-Arginine HCl | |
| levo arginine hydrochloride | |
| 1-Amino-4-guanidovalerate | |
| l arginine monochloride | |
| DL-Arginine | |
| l arginine chloride | |
| bioarginina | |
| 90663-77-7 | |
| arginine residue | |
| arginine monochlorohydrate | |
| arginine content | |
| arginine chloride | |
| arginine chlorhydrate | |
| arginin | |
| conjugate monoacid of L-arginine | |
| labeled with tritium L-Arginine | |
| l a 60 45 | |
| EINECS 239-674-8 | |
| NSC 203450 | |
| Minophagen A | |
| Levargin | |
| L-Arginine, labeled with tritium | |
| 2-amino-5-guanidinovaleric acid | |
| HSDB 1429 | |
| 1-Amino-4-guanidovaleric acid | |
| [amino-(4-amino-4-carboxylato-butyl)amino-methylene]ammonium | |
| L-alpha-Amino-delta-guanidinovaleric acid | |
| L-arginine, conjugate monoacid | |
| L-alpha-Amino-delta-guanidinovalerate | |
| L-a-Amino-d-guanidinovaleric acid | |
| L-a-Amino-d-guanidinovalerate | |
| L-(5-3H)-Arginine | |
| L-(+)-Arginine monohydrochloride | |
| L-(+)-Arginine | |
| L-Arginine monohydrochloride | |
| L-Arginine | |
| AI3-24165 | |
| Detoxargin | |
| L-Arginine hydrochloride | |
| Argamine | |
| NSC 206269 | |
| EINECS 214-275-1 | |
| 5-((aminoiminomethyl)amino)-L-Norvaline | |
| 2-amino-5-guanidinovalerate | |
| (1-carboxy-4-guanidino-butyl)ammonium chloride | |
| (+)-L-Arginine hydrochloride | |
| AI3-18300 | |
| N5-(aminoiminomethyl)-L-Ornithine | |
| EINECS 230-571-3 | |
| S-2-amino-5-((aminoiminomethyl)amino)-Pentanoic acid | |
| S-2-amino-5-((aminoiminomethyl)amino)-Pentanoate | |
| S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid monohydrochloride | |
| NSC 7914 | |
| (+/-)-Arginine | |
| Arginina | |
| (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate | |
| (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoate | |
| (+-)-Arginine |
| KEGG ID | C02385 |
|---|---|
| C00062 |
| MedScan ID | 1249744 |
|---|
| HMDB ID | HMDB00517 |
|---|
| PharmaPendium Name | Arginine Hydrochloride |
|---|
| CAS ID | 142-49-4 |
|---|---|
| 667422-95-9 | |
| 7004-12-8 | |
| 74-79-3 | |
| 1119-34-2 | |
| 7200-25-1 | |
| 15595-35-4 | |
| 4455-52-1 | |
| 90663-77-7 | |
| 17806-42-7 |
| PubChem SID | 134970564 |
|---|---|
| 134988461 | |
| 135024894 | |
| 135038191 | |
| 135043900 | |
| 135102878 | |
| 135192227 | |
| 135269129 | |
| 149262 | |
| 166008 | |
| 171206 | |
| 208328 | |
| 658552 | |
| 662751 | |
| 723513 | |
| 752096 |
| PubChem CID | 6322 |
|---|---|
| 232 | |
| 66250 | |
| 85880 | |
| 6913512 | |
| 28782 |
| XLogP-AA | -3.5 |
|---|
| IUPAC Name | 2-amino-5-guanidino-valeric acid |
|---|---|
| (2S)-2-amino-5-guanidino-valeric acid | |
| (2S)-2-amino-5-(diaminomethyleneammonio)valerate | |
| (2S)-2-amino-5-guanidino-valeric acid;hydrochloride | |
| 2-amino-5-guanidino-valeric acid;hydrochloride | |
| (2S)-2-amino-5-guanidino-5-tritio-valeric acid | |
| (2S)-2-amino-5-guanidino-valeric acid hydrochloride | |
| 2-amino-5-guanidino-valeric acid hydrochloride |
| InChIKey | ODKSFYDXXFIFQN-UHFFFAOYSA-N |
|---|---|
| ODKSFYDXXFIFQN-BYPYZUCNSA-N | |
| KWTQSFXGGICVPE-WCCKRBBISA-N | |
| KWTQSFXGGICVPE-UHFFFAOYSA-N | |
| ODKSFYDXXFIFQN-NBFSVELBSA-N |
| Rotatable Bond Count | 5 |
|---|---|
| 4 |
| Molecular Weight | 174.200960 |
|---|---|
| 174.200960 | |
| 174.200960 | |
| 210.661900 | |
| 210.661900 | |
| 176.209069 | |
| 174.200960 | |
| 174.200960 | |
| 174.200960 | |
| 210.661900 | |
| 210.661900 |
| Molecular Formula | C6H14N4O2 |
|---|---|
| C6H15ClN4O2 |
| XLogP | -4.200000 |
|---|---|
| -4.200000 | |
| -4.200000 | |
| -4.200000 | |
| -4.200000 | |
| -4.200000 | |
| -3.500000 |
| ChEBI ID | 16467 |
|---|---|
| 29016 |
| Reaxys ID | 1725411 |
|---|---|
| 1725412 | |
| 1725413 | |
| 1946577 | |
| 2090768 | |
| 3947900 | |
| 5734096 | |
| 5734097 | |
| 5734098 | |
| 6273768 |
| LinkUrl | http://en.wikipedia.org/wiki/Arginine |
|---|---|
| https://en.wikipedia.org/wiki/Histone#Chemistry_of_histone_modifications |